Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00988962 · ClinicalTrials.gov registry record · NA

Substance Abuse Treatment for High Risk Chronic Pain Patients on Opioid Therapy

A NA study of Substance Abuse, sponsored by Brigham and Women's Hospital.

Completed
Registry status
NA
Development phase
84
Enrollment target
1
Study location

NCT00988962 is a NA study of Substance Abuse that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 84 participants, below the 5,258-participant average among 58 other Substance Abuse trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00988962, a NA study of Substance Abuse, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
NA
Development phase
84 participants
Enrollment target
1
Study location

Study Summary

Chronic back pain patients are often dismissed from a pain center or a primary care practice when they are noncompliant with opioid therapy, instead of being offered treatments to reduce misuse and to improve compliance. Unfortunately, there are few treatment resources for such patients. This study seeks to remedy that problem, with the goal of reducing the rate of prescription opioid misuse among noncompliant patients through the use of novel tracking, education, and counseling interventions.

Conditions Studied

Interventions

  • BEHAVIORAL cognitive behavioral training

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital Pain Management Center - Chestnut Hill

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2009-07
Est. Completion 2011-06
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

What the Registry Record Tells You About NCT00988962

The ClinicalTrials.gov registry entry for NCT00988962 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,258-participant average among 58 other Substance Abuse trials with a reported enrollment target (98% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Substance Abuse appearing as the primary indexed condition, and to 1 intervention - of which cognitive behavioral training is the first listed.

NCT00988962 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00988962 about?

NCT00988962 is a clinical study titled "Substance Abuse Treatment for High Risk Chronic Pain Patients on Opioid Therapy". Chronic back pain patients are often dismissed from a pain center or a primary care practice when they are noncompliant with opioid therapy, instead of being offered treatments to reduce misuse and to improve compliance. Unfortunately, there are few treatment resources for such patients. This study ...

What is the current status of trial NCT00988962?

This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2009-07. Estimated completion is 2011-06.

What conditions does trial NCT00988962 study?

This clinical trial studies the following conditions: Substance Abuse.

What interventions are being tested in trial NCT00988962?

The interventions under investigation include: cognitive behavioral training (BEHAVIORAL).

Who is sponsoring clinical trial NCT00988962?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00988962 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Abuse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.